These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 33429152)

  • 21. 1H magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in bipolar disorder patients.
    Brambilla P; Stanley JA; Nicoletti MA; Sassi RB; Mallinger AG; Frank E; Kupfer D; Keshavan MS; Soares JC
    J Affect Disord; 2005 May; 86(1):61-7. PubMed ID: 15820271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between dorsolateral prefrontal N-acetyl aspartate and depression in chronic back pain: an in vivo proton magnetic resonance spectroscopy study.
    Grachev ID; Ramachandran TS; Thomas PS; Szeverenyi NM; Fredrickson BE
    J Neural Transm (Vienna); 2003 Mar; 110(3):287-312. PubMed ID: 12658377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Proton magnetic resonance spectroscopy of prefrontal lobe and thalamus in schizophrenics: correlation with clinical characteristics].
    Gan JL; Duan HF; Yang JM; Shi ZJ; Zhang DW; Jiang ZK; Gao CY; Wang ZJ
    Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(43):3034-9. PubMed ID: 22333054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proton magnetic resonance spectroscopy in first episode psychosis and ultra high-risk individuals.
    Wood SJ; Berger G; Velakoulis D; Phillips LJ; McGorry PD; Yung AR; Desmond P; Pantelis C
    Schizophr Bull; 2003; 29(4):831-43. PubMed ID: 14989417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between prefrontal N-acetylaspartate and insight in psychotic disorders.
    Larabi DI; Liemburg EJ; Pijnenborg GH; Sibeijn-Kuiper A; de Vos AE; Bais L; Knegtering H; Ćurčić-Blake B; Aleman A
    Schizophr Res; 2017 Jan; 179():112-118. PubMed ID: 27658999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proton Magnetic Resonance Spectroscopy of N-acetyl Aspartate in Chronic Schizophrenia, First Episode of Psychosis and High-Risk of Psychosis: A Systematic Review and Meta-Analysis.
    Whitehurst TS; Osugo M; Townsend L; Shatalina E; Vava R; Onwordi EC; Howes O
    Neurosci Biobehav Rev; 2020 Dec; 119():255-267. PubMed ID: 33068555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship between the alterations in metabolite levels in the dorsolateral prefrontal cortex and clinical symptoms of patients with first-episode schizophrenia: a one year follow-up study.
    Huang M; Guo W; Lu S; Pan F; Chen J; Hu J; Hu S; Xu W; Shang D; Xu Y
    Oncotarget; 2019 Jan; 10(5):606-615. PubMed ID: 30728911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adding Sarcosine to Antipsychotic Treatment in Patients with Stable Schizophrenia Changes the Concentrations of Neuronal and Glial Metabolites in the Left Dorsolateral Prefrontal Cortex.
    Strzelecki D; Podgórski M; Kałużyńska O; Stefańczyk L; Kotlicka-Antczak M; Gmitrowicz A; Grzelak P
    Int J Mol Sci; 2015 Oct; 16(10):24475-89. PubMed ID: 26501260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frontal lobe N-acetylaspartate correlates with psychopathology in schizophrenia: a proton magnetic resonance spectroscopy study.
    Sigmundsson T; Maier M; Toone BK; Williams SC; Simmons A; Greenwood K; Ron MA
    Schizophr Res; 2003 Nov; 64(1):63-71. PubMed ID: 14511802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are working memory and glutamate concentrations involved in early-life stress and severity of psychosis?
    Corcoran M; Hawkins EL; O'Hora D; Whalley HC; Hall J; Lawrie SM; Dauvermann MR
    Brain Behav; 2020 Jun; 10(6):e01616. PubMed ID: 32385970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased glutamate and deep brain atrophy can predict the severity of multiple sclerosis.
    Polacek H; Kantorova E; Hnilicova P; Grendar M; Zelenak K; Kurca E
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2019 Feb; 163(1):45-53. PubMed ID: 30150790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroprotective Effect of Modified Electroconvulsive Therapy for Schizophrenia: A Proton Magnetic Resonance Spectroscopy Study.
    Gan JL; Duan HF; Cheng ZX; Yang JM; Zhu XQ; Gao CY; Zhao LM; Liang XJ
    J Nerv Ment Dis; 2017 Jun; 205(6):480-486. PubMed ID: 28141630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prefrontal grey and white matter neurometabolite changes after atomoxetine and methylphenidate in children with attention deficit/hyperactivity disorder: a (1)H magnetic resonance spectroscopy study.
    Husarova V; Bittsansky M; Ondrejka I; Dobrota D
    Psychiatry Res; 2014 Apr; 222(1-2):75-83. PubMed ID: 24679996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antipsychotic drug effects on left prefrontal phospholipid metabolism: a follow-up 31P-2D-CSI study of haloperidol and risperidone in acutely ill chronic schizophrenia patients.
    Smesny S; Langbein K; Rzanny R; Gussew A; Burmeister HP; Reichenbach JR; Sauer H
    Schizophr Res; 2012 Jul; 138(2-3):164-70. PubMed ID: 22516552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Duration of untreated psychosis vs. N-acetylaspartate and choline in first episode schizophrenia: a 1H magnetic resonance spectroscopy study at 4.0 Tesla.
    Théberge J; Al-Semaan Y; Drost DJ; Malla AK; Neufeld RW; Bartha R; Manchanda R; Menon R; Densmore M; Schaefer B; Williamson PC
    Psychiatry Res; 2004 Jul; 131(2):107-14. PubMed ID: 15313517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations of hippocampal metabolism and regional brain grey matter in neuroleptic-naïve ultra-high-risk subjects and first-episode schizophrenia.
    Nenadic I; Maitra R; Basu S; Dietzek M; Schönfeld N; Lorenz C; Gussew A; Amminger GP; McGorry P; Reichenbach JR; Sauer H; Gaser C; Smesny S
    Eur Neuropsychopharmacol; 2015 Oct; 25(10):1661-8. PubMed ID: 26088723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of functional outcome 18 months after a first psychotic episode: a proton magnetic resonance spectroscopy study.
    Wood SJ; Berger GE; Lambert M; Conus P; Velakoulis D; Stuart GW; Desmond P; McGorry PD; Pantelis C
    Arch Gen Psychiatry; 2006 Sep; 63(9):969-76. PubMed ID: 16952999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal follow-up of neurochemical changes during the first year of antipsychotic treatment in schizophrenia patients with minimal previous medication exposure.
    Bustillo JR; Lauriello J; Rowland LM; Thomson LM; Petropoulos H; Hammond R; Hart B; Brooks WM
    Schizophr Res; 2002 Dec; 58(2-3):313-21. PubMed ID: 12409172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-acetylaspartate levels in bipolar offspring with and at high-risk for bipolar disorder.
    Gallelli KA; Wagner CM; Karchemskiy A; Howe M; Spielman D; Reiss A; Chang KD
    Bipolar Disord; 2005 Dec; 7(6):589-97. PubMed ID: 16403184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal cellular energy and phospholipid metabolism in the left dorsolateral prefrontal cortex of medication-free individuals with bipolar disorder: an in vivo 1H MRS study.
    Frey BN; Stanley JA; Nery FG; Monkul ES; Nicoletti MA; Chen HH; Hatch JP; Caetano SC; Ortiz O; Kapczinski F; Soares JC
    Bipolar Disord; 2007 Jun; 9 Suppl 1():119-27. PubMed ID: 17543030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.